
Ana Lucrecia Woodward
Examiner (ID: 7465, Phone: (571)272-1082 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1796, 1501, 1711, 1765, 1512, 1314, 1504 |
| Total Applications | 3148 |
| Issued Applications | 2104 |
| Pending Applications | 173 |
| Abandoned Applications | 906 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6142098
[patent_doc_number] => 20110129440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/738521
[patent_app_country] => US
[patent_app_date] => 2008-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24036
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129440.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738521
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738521 | Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof | Oct 26, 2008 | Abandoned |
Array
(
[id] => 5337993
[patent_doc_number] => 20090054457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'SUBSTITUTED HETEROCYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/259085
[patent_app_country] => US
[patent_app_date] => 2008-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22882
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12259085
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/259085 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | Oct 26, 2008 | Abandoned |
Array
(
[id] => 5576044
[patent_doc_number] => 20090143406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'New Phenylpiperazine'
[patent_app_type] => utility
[patent_app_number] => 12/258591
[patent_app_country] => US
[patent_app_date] => 2008-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5316
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12258591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/258591 | Phenylpiperazine | Oct 26, 2008 | Issued |
Array
(
[id] => 6630928
[patent_doc_number] => 20100311749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => '4-BENZOYL-1-SUBSTITUTED-PIPERAZIN-2-ONE DERIVATIVES AS P2X7 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/739462
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28243
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311749.pdf
[firstpage_image] =>[orig_patent_app_number] => 12739462
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739462 | 4-BENZOYL-1-SUBSTITUTED-PIPERAZIN-2-ONE DERIVATIVES AS P2X7 MODULATORS | Oct 23, 2008 | Abandoned |
Array
(
[id] => 5285524
[patent_doc_number] => 20090099199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/251627
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21691
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099199.pdf
[firstpage_image] =>[orig_patent_app_number] => 12251627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/251627 | ORGANIC COMPOUNDS | Oct 14, 2008 | Abandoned |
Array
(
[id] => 217166
[patent_doc_number] => 07612076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'Piperazinyl-pyridine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/246523
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15998
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/612/07612076.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246523 | Piperazinyl-pyridine derivatives | Oct 6, 2008 | Issued |
Array
(
[id] => 4515027
[patent_doc_number] => 07910588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => '5-HT7 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/678345
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13293
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910588.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678345
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678345 | 5-HT7 receptor antagonists | Sep 29, 2008 | Issued |
Array
(
[id] => 5429131
[patent_doc_number] => 20090088441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Quinoline Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/238982
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14801
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088441.pdf
[firstpage_image] =>[orig_patent_app_number] => 12238982
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/238982 | Quinoline Compounds | Sep 25, 2008 | Abandoned |
Array
(
[id] => 5509156
[patent_doc_number] => 20090082363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'DEUTERIUM-ENRICHED POSACONAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/234229
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3993
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082363.pdf
[firstpage_image] =>[orig_patent_app_number] => 12234229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/234229 | DEUTERIUM-ENRICHED POSACONAZOLE | Sep 18, 2008 | Abandoned |
Array
(
[id] => 4609463
[patent_doc_number] => 07994174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Pyridyl sulfonamides as modulators of ion channels'
[patent_app_type] => utility
[patent_app_number] => 12/212063
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20684
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/994/07994174.pdf
[firstpage_image] =>[orig_patent_app_number] => 12212063
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/212063 | Pyridyl sulfonamides as modulators of ion channels | Sep 16, 2008 | Issued |
Array
(
[id] => 4570378
[patent_doc_number] => 07858620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Cyanoisoquinoline'
[patent_app_type] => utility
[patent_app_number] => 12/208799
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11721
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208799
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208799 | Cyanoisoquinoline | Sep 10, 2008 | Issued |
Array
(
[id] => 5297173
[patent_doc_number] => 20090012099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Novel Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/208543
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3922
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208543 | Novel Compounds | Sep 10, 2008 | Abandoned |
Array
(
[id] => 5272252
[patent_doc_number] => 20090076028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ITRACONAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/207861
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3921
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076028.pdf
[firstpage_image] =>[orig_patent_app_number] => 12207861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/207861 | DEUTERIUM-ENRICHED ITRACONAZOLE | Sep 9, 2008 | Abandoned |
Array
(
[id] => 5361888
[patent_doc_number] => 20090036682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Quinoline Derivatives and Their Use as 5-HT6 Ligands'
[patent_app_type] => utility
[patent_app_number] => 12/205079
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15620
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036682.pdf
[firstpage_image] =>[orig_patent_app_number] => 12205079
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/205079 | Quinoline derivatives and their use as 5-HT6 ligands | Sep 4, 2008 | Issued |
Array
(
[id] => 4548471
[patent_doc_number] => 07960385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Guanidine-containing compounds useful as muscarinic receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/231861
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26681
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960385.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231861 | Guanidine-containing compounds useful as muscarinic receptor antagonists | Sep 4, 2008 | Issued |
Array
(
[id] => 5436282
[patent_doc_number] => 20090170869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/203946
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25484
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170869.pdf
[firstpage_image] =>[orig_patent_app_number] => 12203946
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/203946 | PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR | Sep 3, 2008 | Abandoned |
Array
(
[id] => 6537586
[patent_doc_number] => 20100204242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Piperazine Derivative Having Affinity for the Histamine H3 Receptor'
[patent_app_type] => utility
[patent_app_number] => 12/676158
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25480
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676158
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676158 | Piperazine derivative having affinity for the histamine H3 receptor | Sep 3, 2008 | Issued |
Array
(
[id] => 53280
[patent_doc_number] => 07772226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Condensed imidazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/199982
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90953
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772226.pdf
[firstpage_image] =>[orig_patent_app_number] => 12199982
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/199982 | Condensed imidazole derivatives | Aug 27, 2008 | Issued |
Array
(
[id] => 5272251
[patent_doc_number] => 20090076027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED LURASIDONE'
[patent_app_type] => utility
[patent_app_number] => 12/196722
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3963
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196722
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196722 | DEUTERIUM-ENRICHED LURASIDONE | Aug 21, 2008 | Abandoned |
Array
(
[id] => 4648
[patent_doc_number] => 07812021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Pyrrolidine aryl-ether as NK3 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/195545
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16607
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812021.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195545 | Pyrrolidine aryl-ether as NK3 receptor antagonists | Aug 20, 2008 | Issued |